FDA planning pilot program for innovative trial designs

FDA intends to launch by year end a pilot program for complex innovative designs of clinical trials, according to a notice in the Federal Register. The agency will seek input on the program at a public meeting March 20, and intends to publish a draft guidance within 18 months of the meeting...